Quick facts
- An EDTA tube is an anticoagulant blood tube: the anticoagulant binds calcium so the blood does not clot, which is what makes it usable for cell counts rather than for serum.
- The colour code is not the specification. Lavender and pink tubes in many systems both contain EDTA; what separates them is the additive formulation and the intended test, not the cap.
- United States: 21 CFR 862.1675 covers the blood specimen collection device and states that the generic device "may include blood collection tubes, vials, systems, serum separators, blood collection trays, or vacuum sample tubes". It is classified as Class II.
- That class is worth noticing. The same rulebook puts the collection swab and labware entries in Class I, so the blood collection device sits in a different tier from the consumables around it.
- Canada: the Medical Devices Regulations, SOR/98-282 classify by definitions and Schedule 1 rules, so there is no matching named entry to look up.
- Order of draw is a fill-and-additive question. A tube drawn in the wrong sequence can be contaminated by the additive in the tube before it, and the error is invisible on the label.
An EDTA tube looks like every other blood tube in the rack and behaves differently from most of them. It is the reference container for haematology, it interferes with assays that depend on calcium, and whether it can be used at all depends on where in the draw sequence it was filled.
This article sets out what the tube is, how each country treats it in the device framework, why order of draw matters, how the specimen travels, and what a phlebotomy station consumes.
What is an EDTA tube and why does the anticoagulant matter?
An EDTA tube contains ethylenediaminetetraacetic acid, usually as a dipotassium or tripotassium salt, and it works by binding calcium ions. Coagulation depends on calcium, so removing it from the available pool prevents the cascade from completing and the specimen stays liquid.
That mechanism produces three practical consequences.
EDTA tubes are for cellular work. Because the cells are preserved rather than clotted out, EDTA specimens are the standard container for full blood counts, differentials, and many haematology and molecular assays run on whole blood.
EDTA interferes with calcium-dependent tests. A specimen that has been chelated cannot be used to assess clotting, and it distorts analytes affected by the additive. This is why the coagulation tube is drawn separately and why the two cannot be treated as interchangeable.
Concentration matters as much as presence. Spray-dried and liquid additives behave differently, tubes are filled to a marked volume for a reason, and an underfilled tube changes the additive-to-blood ratio. A short draw is a specimen problem, not a paperwork problem.
Is an EDTA tube a regulated device in the United States?
Yes, and it sits in a different class from the consumables around it. 21 CFR 862.1675 states:
"A blood specimen collection device is a device intended for medical purposes to collect and to handle blood specimens and to separate serum from nonserum (cellular) components prior to further testing. This generic type device may include blood collection tubes, vials, systems, serum separators, blood collection trays, or vacuum sample tubes."
The classification is Class II. That single word separates this entry from the neighbouring ones. The absorbent tipped applicator at 21 CFR 880.6025 is Class I, the microbiological specimen collection and transport device at 21 CFR 866.2900 is Class I, and the general purpose reagent entry at 21 CFR 864.4010 — the one that folds in labware and disposable constituents of tests — is Class I with a conditional exemption from the quality system regulation.
For a buyer, the practical reading is that "blood tube" and "swab" are not the same regulatory animal in the United States, even though both are consumables bought in cases. The blood collection device entry carries a higher class, and the specification claims that come with it — fill volume, additive, sterility, expiry — are the reason.
Does Canada classify EDTA tubes the same way?
No. Canada works from definitions rather than from named entries, so a tube's status follows from its labelling and from the rules in Schedule 1 rather than from a matching published line.
| Item | Canada | United States |
|---|---|---|
| Classification approach | Definitions plus Schedule 1 rules | Named device entry |
| Entry for a blood collection tube | No named entry; status follows the labelling | 21 CFR 862.1675, blood specimen collection device |
| Assigned class | Class I where the device route applies and the device is non-invasive | Class II |
| Premarket route | Device licence where the class requires it | Premarket requirements apply to the class, not an exemption |
| Neighbouring consumables | Assessed case by case | Swab entry and labware entry both Class I |
| What a buyer can cite | Labelling, instructions for use and the licence where one applies | The named identification and its class |
CliniEco Medical holds Health Canada MDEL #35334 as an establishment, which is a licence to import and distribute devices in Canada. It is not a statement about any individual tube.
Why does order of draw matter, and what does it change?
Order of draw exists because tubes share a needle, a hub and a vein, and additives travel.
The mechanism is contamination rather than chemistry. When a tube is removed and the next is attached, additive from the first tube can be carried back into the hub and then into the next specimen. A tissue-plasminogen-activator additive or a heparin additive reaching a specimen intended for a different assay changes that assay's result, and nothing on the label of the affected tube reveals it.
The sequence published by CLSI is the reference used across North America, and CLSI's summary of order of draw tubes and additives is the accessible description of it. In outline, the sequence runs from the least additive-affected to the most: blood culture bottles first where they are drawn, then the coagulation tube, then serum tubes, then heparin tubes, then the EDTA tube, then the tubes containing glycolysis inhibitors. The WHO guidelines on drawing blood cover the same ground for a global audience, and ISO 6710:2017 covers the single-use containers themselves.
| Item | Canada | United States |
|---|---|---|
| Reference order of draw | CLSI sequence, applied by laboratories and collection centres | The same CLSI sequence |
| Which tube is drawn along with EDTA | Coagulation tube ahead of it, in a separate citrate tube | The same sequence |
| Where the requirement is written | Laboratory procedure documents and provincial licensing requirements | Laboratory procedure documents and accreditation requirements |
| Consequence of breaking the sequence | Specimen rejection and repeat collection | The same |
| Filling requirement | Fill to the marked volume, because ratio matters | The same |
What does the record have to show?
A specimen travels with paperwork, and the paperwork is what decides whether the laboratory accepts it.
Ontario licenses laboratories and specimen collection centres under the Laboratory and Specimen Collection Centre Licensing Act, R.S.O. 1990, c. L.1, with the detail in O. Reg. 45/22. The profession is regulated by the College of Medical Laboratory Technologists of Ontario, and laboratory accreditation in the province is delivered through the Institute for Quality Management in Healthcare. ISO 15189:2022 is the standard applied to medical laboratories and reaches the pre-examination processes, which is where specimen acceptance and rejection live.
In practice the record has to show the patient identifier, the date and time of collection, the tube type and additive, the fill status where it is in question, the collector's identifier, and any deviation from the standard sequence. A tube that arrives without that information is not made acceptable by being the right colour.
Transport adds a second layer. Canada's Transportation of Dangerous Goods Regulations, SOR/2001-286 and the US provisions at 49 CFR 173.199 both apply UN packaging logic: leakproof primary container, absorbent material, rigid secondary container, and compliant outer packaging. Where human pathogens are handled, the Canadian Biosafety Standard sets the containment requirements.
For the people holding the needle, two rules apply on either side of the border. 29 CFR 1910.1030 sets the bloodborne pathogens requirements for the US employer, and Ontario's O. Reg. 474/07 sets out needle safety duties in the province.
Which consumables does a blood collection station consume?
- The tubes themselves. EDTA tubes in the fill volumes the analyser accepts, plus the neighbouring tubes in the draw sequence. The colour code is the starting point for identification and not the specification.
- Needles and holders. Where a winged set is used, the gauge and the safety-engineered feature are the specification, and Ontario's needle safety rule reaches the choice. Sterile centrifuge tubes and larger 50 mL tubes cover the processing end of the bench.
- Wipes, swabs and dressings. Antiseptic preparation, individually wrapped cotton swabs for the site, and sterile gauze sponges with tape for the dressing.
- Containers and transport packaging. Sterile specimen containers with screw caps cover the non-blood collection work on the same bench, and 95 kPa specimen transport bags are the packaging layer.
- Gloves and sharps. Nitrile examination gloves are consumed on contact, and the sharps container is the item whose fill line and replacement cycle belong on the station checklist.
Sources
- 21 CFR 862.1675, blood specimen collection device
- 21 CFR 862.1675, eCFR current text
- 21 CFR 864.4010, general purpose reagent
- 21 CFR 866.2900, microbiological specimen collection and transport device
- 21 CFR 880.6025, absorbent tipped applicator
- CLSI, order of blood draw tubes and additives
- ISO 6710:2017, single-use containers for venous blood specimen collection
- ISO 15189:2022, medical laboratories
- WHO guidelines on drawing blood
- Medical Devices Regulations, SOR/98-282
- Laboratory and Specimen Collection Centre Licensing Act, R.S.O. 1990, c. L.1
- O. Reg. 45/22, general
- O. Reg. 474/07, needle safety
- College of Medical Laboratory Technologists of Ontario
- Institute for Quality Management in Healthcare
- Public Health Ontario, laboratory test information index
- Transportation of Dangerous Goods Regulations, SOR/2001-286
- 49 CFR 173.199, Category B infectious substances
- 29 CFR 1910.1030, bloodborne pathogens
- Canadian Biosafety Standard
Ordering for a clinic, lab or care home? Wholesale and multi-site ordering covers account setup and case pricing, and the B2B wholesale collection lists the lines stocked for institutional buyers. Clinics that also run an in-house sterilizer can start with the biological indicator 5-pack trial.
Related reading
- Serum separator tubes in Canada vs the US: order of draw
- Butterfly needles in Canada vs the US: gauge sizing
- Customary specimen collection containers: urine cups and 24-hour collection
- Microcentrifuge tubes in Canada vs the US: which standards
- Nasopharyngeal swabs in Canada vs the US: which collection rules
Frequently Asked Questions
What is an EDTA tube used for?
Specimens that need the cells preserved rather than clotted out, which in practice means haematology and the whole-blood assays that depend on intact cells. The anticoagulant binds calcium so the coagulation cascade cannot complete. It is the wrong container for any test that depends on calcium being available, which is why the coagulation tube is drawn separately.
Is an EDTA tube a Class I or Class II device in the United States?
Class II. The blood specimen collection device entry at 21 CFR 862.1675 states that the generic device may include blood collection tubes, vials, systems, serum separators, blood collection trays or vacuum sample tubes, and classifies it as Class II. That is a higher tier than the Class I entries covering collection swabs and labware.
Does the cap colour tell you what is in the tube?
Not reliably across suppliers and not on its own. Lavender and pink tubes in common systems both contain EDTA, and the difference that matters clinically is the additive formulation and the intended test rather than the colour. The specification, the fill volume and the expiry are the parts of the label to read before the colour.
Why does order of draw matter for an EDTA tube?
Because additives travel between tubes when a needle is reused across a sequence. Additive carried from the previous tube into the next specimen can change the result of the assay run on it, and the affected tube carries no indication that it happened. The CLSI order of draw sequence exists to make that contamination predictable and avoidable.
What happens if an EDTA tube is underfilled?
The additive-to-blood ratio changes, because the tube holds a fixed quantity of anticoagulant. An underfilled tube can produce results that do not reflect the patient. This is why tubes are filled to a marked volume and why fill status is part of the record when a specimen is questioned.
What does the collection record have to show?
The patient identifier, the date and time of collection, the tube type and additive, the collector's identifier, and any deviation from the standard sequence. ISO 15189:2022 reaches the pre-examination processes in medical laboratories, and specimen acceptance or rejection is decided there rather than at the analyser.
CliniEco Medical supplies specimen collection consumables, laboratory lines and the wider clinic catalogue described in this article. Health Canada MDEL #35334. This article is written for clinic, laboratory and procurement professionals and is not clinical guidance; specimen requirements and draw technique belong to the laboratory and the trained collector.
0 comments